West Coast Financial LLC Amgen Inc Transaction History

West Coast Financial LLC

$844 Million
Q2 2024

A detailed history of West Coast Financial LLC transactions in Amgen Inc stock. As of the latest transaction made, West Coast Financial LLC holds 2,935 shares of AMGN stock, worth $938,407. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,935

Previous 3,323 11.68%

Holding current value

$938,407

Previous $944,000 2.86%

% of portfolio

0.11%

Previous 0.11%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $101,947 - $123,892	-388 Reduced 11.68%	2,935 $917,000
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $110,774 - $133,718	-412 Reduced 11.03%	3,323 $944,000
Q4 2023 Jan 11, 2024	SELL	$255.7 - $288.46 $5.01 Million - $5.66 Million	-19,612 Reduced 84.0%	3,735 $1.08 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $197,222 - $244,856	-902 Reduced 3.72%	23,347 $6.27 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $40,497 - $47,886	-189 Reduced 0.77%	24,249 $5.38 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $27,320 - $33,299	121 Added 0.5%	24,438 $5.91 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $38,706 - $49,180	169 Added 0.7%	24,317 $6.39 Million
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $69,807 - $78,729	311 Added 1.3%	24,148 $5.44 Million
Q2 2022 Jul 11, 2022	BUY	$230.71 - $256.74 $95,052 - $105,776	412 Added 1.76%	23,837 $5.8 Million
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $102,618 - $113,522	468 Added 2.04%	23,425 $5.67 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $35,201 - $40,285	177 Added 0.78%	22,957 $5.17 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $132,031 - $154,691	622 Added 2.81%	22,780 $4.84 Million
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $24,525 - $27,209	105 Added 0.48%	22,158 $5.4 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $4.63 Million - $5.39 Million	20,856 Added 1742.36%	22,053 $5.49 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $23,465 - $26,095	-100 Reduced 7.71%	1,197 $304,000
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $22,051 - $29,245	-121 Reduced 8.53%	1,297 $263,000
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $15,893 - $20,428	-84 Reduced 5.59%	1,418 $342,000
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $261,513 - $313,347	1,502 New	1,502 $291,000
Q2 2019 Jul 16, 2019	SELL	$166.7 - $195.41 $291,558 - $341,772	-1,749 Closed	0 $0
Q1 2019 Apr 22, 2019	SELL	$180.87 - $203.88 $17,363 - $19,572	-96 Reduced 5.2%	1,749 $332,000
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $114,354 - $133,488	-641 Reduced 25.78%	1,845 $359,000
Q3 2018 Oct 19, 2018	BUY	$185.29 - $208.89 $101,168 - $114,053	546 Added 28.14%	2,486 $515,000
Q2 2018 Jul 16, 2018	SELL	$166.05 - $186.51 $7,804 - $8,765	-47 Reduced 2.37%	1,940 $358,000
Q1 2018 Apr 17, 2018	BUY	$169.43 - $198.0 $4,744 - $5,544	28 Added 1.43%	1,987 $339,000
Q4 2017 Jan 19, 2018	SELL	$168.79 - $188.59 $71,229 - $79,584	-422 Reduced 17.72%	1,959 $341,000
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $398,317 - $454,771	2,381	2,381 $444,000

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Coast Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Coast Financial LLC with notifications on news.

Account

West Coast Financial LLC Amgen Inc Transaction History